3-Hydrazinoindolin-2-one derivatives: Chemical classification and investigation of their targets as anticancer agents

Eur J Med Chem. 2016 Oct 21:122:366-381. doi: 10.1016/j.ejmech.2016.06.034.

Hany S Ibrahim ¹, Sahar M Abou-Seri ², Hatem A Abdel-Aziz ³

Affiliations

1 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Egyptian Russian University, Badr City, Cairo 11829, Egypt. Electronic address: [email protected].
2 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo 11562, Egypt.
3 Department of Applied Organic Chemistry, National Research Centre, Dokki, Cairo 12622, Egypt.

PMID: 27391135 DOI: 10.1016/j.ejmech.2016.06.034

Abstract

Isatin is a well acknowledged pharmacophore in many clinically approved drugs used for treatment of Cancer. 3-Hydrazinoindolin-2-one, as a derivative of isatin, represents a pharmacophore of an important class of biologically active pharmaceutical agents by virtue of their diverse biological activities. In this review, Anticancer activity will be on focus for compounds derived from 3-hydrazinoindolin-2-one. They are classified according to their chemical structure into nine different classes. In each class, different compounds were browsed, showing their Anticancer activity and their potential targets. Moreover, crystallographic data or docking studies were highlighted for some compounds, when available, to provide a deep understanding of their mechanisms of action.

Keywords

3-Hydrazinoindolin-2-one; Anticancer; Isatin.

Name
Email *

	Sorry, but the email address you supplied was invalid.